2023
DOI: 10.1136/ijgc-2022-003955
|View full text |Cite
|
Sign up to set email alerts
|

Opioid and benzodiazepine use in gynecologic oncology patients

Abstract: ObjectiveThe goals of this study were to describe opioid and benzodiazepine prescribing practices in the gynecologic oncology patient population and determine risks for opioid misuse in these patients.MethodsRetrospective study of opioid and benzodiazepine prescriptions for patients treated for cervical, ovarian (including fallopian tube/primary peritoneal), and uterine cancers within a single healthcare system from January 2016 to August 2018.ResultsA total of 7643 prescriptions for opioids and/or benzodiazep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…Cancer-related pain is a highly prevalent subjective symptom observed in patients with gynecologic malignancies ( 11 ). The nature of pain experienced by patients is generally dull and of a moderate degree.…”
Section: Introductionmentioning
confidence: 99%
“…Cancer-related pain is a highly prevalent subjective symptom observed in patients with gynecologic malignancies ( 11 ). The nature of pain experienced by patients is generally dull and of a moderate degree.…”
Section: Introductionmentioning
confidence: 99%